Genes upregulated during castration-induced rat prostatic apoptosis: cloning and characterization of new cDNAs

被引:12
作者
Bruyninx, M [1 ]
Ammar, H [1 ]
Reiter, E [1 ]
Cornet, A [1 ]
Closset, J [1 ]
机构
[1] Univ Liege, Inst Pathol B23, Lab Endocrinol, Dept Biochem, B-4000 Liege, Belgium
关键词
programmed cell death; castration; prostate; thymus; IGFBP; differential display;
D O I
10.1046/j.1464-410x.2000.00654.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To isolate new cDNAs corresponding to genes whose expression is increased during castration-induced rat prostate apoptosis. Materials and methods Differential display of mRNAs from 3-day castrated and normal rat ventral prostates was used to identify differentially expressed clones. Northern blots were hybridized to confirm the positive regulation of the candidates and to follow the change in their expression in the involuting rat prostate, and in thymocytes of dexamethazone-treated rats. Results Five cDNAs were cloned: one encoding ribosomal protein L7, one coding for the insulin-like growth factor binding protein-3 (IGFBP-3), and three whose products are unknown. After castration, all five genes had expression kinetics that closely paralleled the proportion of prostatic epithelial cells undergoing apoptosis. The gene encoding L7 and two of the unknown genes were also upregulated in glucocorticoid-induced programmed death in thymocytes. In addition to the IGFBP-3 gene, those coding for proteins IGFBP-4, -5 and -6 were also overexpressed in the involuting prostate of androgen-deprived rats. Conclusion Five new genes were identified that are upregulated during castration-induced rat prostate apoptosis, three of which are potentially involved in the common intracellular pathway leading to programmed cell death.
引用
收藏
页码:1134 / 1142
页数:9
相关论文
共 44 条
[41]   DUCTAL HETEROGENEITY OF CYTOKERATINS, GENE-EXPRESSION, AND CELL-DEATH IN THE RAT VENTRAL PROSTATE [J].
ROULEAU, M ;
LEGER, J ;
TENNISWOOD, M .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :2003-2013
[42]  
Suzuki A, 1996, ONCOGENE, V13, P31
[43]  
Thomas LN, 1998, PROSTATE, V35, P273
[44]  
Wang JD, 1999, PROSTATE, V40, P50